You searched for viral vector - Page 13 of 53

In Depth 27 Jun 2024

CRISPR-Cas13: how does the technology compare to its famous Cas9 cousin?

…to reduce the levels of newly synthesized viral RNA, but also target and destroy viral RNA entering cells within the viral capsid, resulting in a strong inhibitory effect on HIV-1…

June 27, 2024 - 7 minutesmins - By Willow Shah-Neville

News and Trends 12 Oct 2017

No More Seasonal Flu Shots: British Biotech’s Universal Antiviral Raises £13M

VirionHealth kicks off the development of a broad spectrum antiviral for all influenza strains and other viruses like RSV with a £13M investment in Series A. VirionHealth is developing a…

October 12, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

influenza virus antiviral drugs atriva therapeutics germany tuebingen 1

News and Trends 8 Mar 2019

Flu Resistant to Antivirals? This Biotech Has a Drug for That

…them like a shield. For the same reason, safe antiviral drugs are very hard to develop. In fact, the latest flu antiviral to be approved, Xofluza in 2018, came 20…

March 8, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 20 Oct 2016

German Record-deal Antiviral drug Succeeds in Phase III

…payment for AiCuris. Letermovir is an antiviral drug against human cytomegalovirus (CMV), which is responsible for severe infections and death of immunocompromised patients. Although no details have been released for…

October 20, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

In Depth 7 May 2025

Unlocking immunity: the power of TLR agonists

…high production of signaling proteins like interferons in response to viral infections – which are essential for initiating antiviral defenses. American biotech Eikon Therapeutics has a clinical candidate that is…

May 7, 2025 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 31 Oct 2022

Replay Bio launches HSV gene therapy company to target retinal eye disease

…1B. Replay’s synHSV technology is a high payload capacity gene-deleted HSV-1 vector capable of delivering up to eight times the payload of adeno-associated virus (AAV) vectors. This facilitates the delivery…

October 31, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 22 Jun 2022

Cystic fibrosis in the crosshairs as Carbon Biosciences launches with $38M funding

…of genetic medicines with differentiated vectors that have the potential to address the immunological, targeting and payload limitations inherent in current viral and non-viral delivery technologies. “As the first jointly…

June 22, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 28 Jan 2016

Viral Immunotherapy Trial Failure Causes French Biotech Stocks to Drop 43%

…explained: The analysis to date shows clear separation in the viral clearance rates in two key subgroups and support our expectations to see superiority in viral clearance in the treated…

January 28, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 18 Apr 2019

Hookipa’s €75M IPO to Fund Vaccines for Viral Infection and Cancer

…and the first clinical trials of its cancer vaccines. Based in Vienna, Hookipa develops vaccines based on engineered viruses called arenavirus. The company programs arenaviruses to express antigens mimicking viral…

April 18, 2019 - 3 minutesmins - By Jonathan Smith

Expert Advice 30 Aug 2018

7 Ingredients a Life Science Infographic Needs to Go Viral

…infographics. The next question is how do you make it as good as it can be and give it the best possible chance of going viral? 1. Choose a…

August 30, 2018 - 9 minutesmins - By James Mathison

Interview 12 Jun 2019

How Vaccines Could One Day Beat HIV

…was essentially a death sentence. Nowadays, though, HIV-positive people can take daily antiretroviral drugs, which stop the virus from spreading. Labiotech Refresh in Barcelona last May “The world of HIV…

June 12, 2019 - 5 minutesmins - By Jonathan Smith

News and Trends 22 Oct 2019

Austrian Biotech Will Develop Viral Protein For Vaginal Infection

The Austrian biotech company PhagoMed Biopharma is developing a viral protein that could one day treat the common condition bacterial vaginosis without disrupting the microbiome as traditional antibiotics do. The…

October 22, 2019 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

CRISPR-Cas13: how does the technology compare to its famous Cas9 cousin?

No More Seasonal Flu Shots: British Biotech’s Universal Antiviral Raises £13M

Flu Resistant to Antivirals? This Biotech Has a Drug for That

German Record-deal Antiviral drug Succeeds in Phase III

Unlocking immunity: the power of TLR agonists

Replay Bio launches HSV gene therapy company to target retinal eye disease

Cystic fibrosis in the crosshairs as Carbon Biosciences launches with $38M funding

Viral Immunotherapy Trial Failure Causes French Biotech Stocks to Drop 43%

Hookipa’s €75M IPO to Fund Vaccines for Viral Infection and Cancer

7 Ingredients a Life Science Infographic Needs to Go Viral

How Vaccines Could One Day Beat HIV

Austrian Biotech Will Develop Viral Protein For Vaginal Infection

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!